Formula (Vigabatrin Tablets 1)
Vigabatrin Tablet
Product Images NDC 69238-1424
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 69238-1424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Vigabatrin Tablets 2)
Figure 2 (Vigabatrin Tablets 3)
The text describes a figure (Figure 2) that shows the percentage reduction in seizure frequency in patients. The figure has a line graph with a horizontal axis indicating the percentage of patients, and a vertical axis indicating the percentage reduction in seizure frequency. The graph has a midpoint line and a scale for worsening or improving.*
500 mg 100ct Label (Vigabatrin Tablets 4)
This is a prescription medication called Vigabatrin which comes in the form of film-coated tablets used to treat seizures. Each tablet contains 500mg of the active ingredient, and it is typically administered as directed by a physician. The medication guide must be dispensed with the medication, and storage must take place in a tight container at 20 to 25 degrees Celsius. It is manufactured and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The NDC number is 69238-1424-1. The usual dosage instructions are available in the package insert for full prescribing information. No lot number or expiration date is available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
